No problems
have been found with a hepatitis B vaccine which was suspected of causing the
deaths of 17 children after they received injections, China's health
authorities said Friday.
Samples of
1,315 vaccine shots manufactured in six batches by domestic producer BioKangtai
had been tested as of Jan. 14, the China Food and Drug Administration and the
National Health and Family Planning Commission said in a joint statement.
All samples
met the standards of enterprise registration and the national pharmacopoeia,
the two agencies said.
Analysis
showed the 17 deaths had nothing to do with the vaccine. The possibility of
another child, who was discharged from hospital, suffering a reaction from the
vaccine has not been ruled out.
The 17
deaths were due to various problems, including severe pneumonia, kidney failure
and suffocation, according to the statement.
Authorities
have resumed the use of BioKangtai's hepatitis B vaccines.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.